microdosing semaglutide vs tirzepatide for weight loss Semaglutide vs. Tirzepatide: Which GLP-1

The American Diabetes Association does not endorse microdosing

The triple agonist mechanism targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously

you're also losing lean mass, including muscle, water, bone and other tissue

[1] [3] For type 2 diabetes, semaglutide is typically initiated at 0.25 mg subcutaneously once weekly, with gradual dose escalation to a maintenance dose of 0.5 mg, 1 mg, or 2 mg depending on glycemic response and tolerability

What Thousands of Happy Members Have to Say Check our catalogue of ready to use medications

Your body composition transformation depends not just on the number on the scale, but on what that weight is made of